Death domain containing receptors

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S252300, C435S320100, C536S023500

Reexamination Certificate

active

06951735

ABSTRACT:
The present invention relates to novel Death Domain Containing Receptor (DR3 and DR3-V1) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR3 and DR3-V1 proteins. DR3 and DR3-V1 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR3 and DR3-V1 activity.

REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 5120525 (1992-06-01), Goldenberg
patent: 5395760 (1995-03-01), Smith et al.
patent: 5464938 (1995-11-01), Smith et al.
patent: 5656272 (1997-08-01), Le et al.
patent: 0 585 939 (1994-03-01), None
patent: WO 94/09137 (1994-04-01), None
patent: WO 94/13808 (1994-06-01), None
patent: WO 97/33904 (1997-09-01), None
patent: WO 97/37020 (1997-10-01), None
patent: WO 98/14565 (1998-04-01), None
patent: WO 98/32856 (1998-07-01), None
Adams, M.D. et al., “Complementary DNA Sequencing: Expressed Sequence Tags and Human Genome Project,”Science 252:1651-1656 (1991).
Adams, M.D. et al., “Sequence identification of 2,375 human brain genes,”Nature 355:632-634 (1992).
Aggarwal, B.B. and K. Natarajan, “Tumor necrosis factors: Developments during the last decade,”Eur. Cytokine Netw. 7(2):93-124 (Apr.-Jun. 1996).
Altschul, S.F. et al., “Basic Local Alignment Search Tool,”J. Mol. Biol. 215:403-410 (1990).
Ansari, A.A. et al., “HLA-D gene studies in relation to immune responsiveness to a grass allergen LoI p III,”Immunogenet. 33:24-32 (1991).
Armitage, R.J., “Tumor necrosis factor receptor superfamily members and their ligands,”Curr. Opin. Immunol 6:407-413 (Jun. 1994).
Baens, M. et al., “Construction and Evaluation of a hncDNA Library of Human 12p Transcribed Sequences Derived from a Somatic Cell Hybrid,”Genomics 16:214-218 (1993).
Baker, E. et al., “Chromosomal location of the human tumor necrosis factor receptor genes,”Cytogenet. Cell Genet. 57:117-118 (1991).
Banchereau, J. et al., “Long-Term Human B Cell Lines Dependent on Interleukin-4 and Antibody to CD40,”Science 251:70-72 (1991).
Banner, D.W. et al., “Crystal Structure of the Soluble Human 55 kd Receptor-Human TNFβ Complex: Implications for TNF Receptor Activation,”Cell 73:431-445 (1993).
Baum, P.R. et al., “Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34,”EMBO J. 13(17):3992-4001 (Sep. 1994).
Birkeland, M.L. et al., “Gene structure and chromosomal localization of the mouse homologue of rat OX40 protein,”Eur. J. Immunol. 25:926-930 (Apr. 1995).
Bodmer, J.-L. et al., “TRAMP, a Novel Apoptosis-Mediating Receptor with Sequence Homology to Tumor Necrosis Factor Receptor 1 and Fas(Apo-1/CD95),”Immunity 6:79-88 (Jan. 1997).
Camerini, D. et al., “The T Cell Activation Antigen CD27 Is a Member of the Nerve Growth Factor/Tumor Necrosis Factor Receptor Gene Family,”J. Immunol. 147(9):3165-3169 (1991).
Chinnaiyan, A.M. et al., “Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95,”Science 274:990-992 (Nov. 1996).
Dürkop, H. et al., “Molecular Cloning and Expression of a New Member of the Nerve Growth Factor Receptor Family That Is Characteristic for Hodgkin's Disease,”Cell 68:421-427 (1992).
Engelmann, H. et al., “Two Tumor Necrosis Factor-binding Proteins Purified from Human Urine,”J. Biol. Chem. 265(3):1531-1536 (1990).
Feinstein, E. et al., “The death domain: a module shared by proteins with diverse cellular functions,”TIBS 20:342-344 (Sep. 1995).
Gillette-Ferguson, I. and C.L. Sidman, “A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice,”Eur. J. Immunol. 24:1181-1185 (May 1994).
Goodwin, R.G. et al., “Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor,”Eur. J. Immunol. 23:2631-2641 (1993).
Gruss, H.-J et al., “Pleiotropic Effects of the CD30 Ligand on CD30-Expressing Cells and Lymphoma Cell Lines,”Blood 83(8):2045-2056 (Apr. 1994).
Himmler, A. et al., “Molecular Cloning and Expression of Human and Rat Tumor Necrosis Factor Receptor Chain (p60) and Its Soluble Derivative, Tumor Necrosis Factor-Binding Protein,”DNA and Cell Biol. 9(10):705-715 (1990).
Hohmann, H.-P. et al., “Two Different Cell Types Have Different Major Receptors for Human Tumor Necrosis Factor (TNFα),”J. Biol. Chem. 264(25):14927-14934 (1989).
Howard, S.T. et al., “Vaccinia Virus Homologues of the Shope Fibroma Virus Inverted Terminal Repeat Proteins and a Discontinuous ORF Related to the Tumor Necrosis Factor Receptor Family,”Virol. 180:633-647 (1991).
Hsu, K.C. and M.V. Chao, “Differential Expression and Ligand Binding Properties of Tumor Necrosis Factor Receptor Chimeric Mutants,”J. Biol. Chem. 268(22):16430-16436 (1993).
Hu, F.-Q. et al., “Cowpox Virus Contains Two Copies of an Early Gene Encoding a Soluble Secreted Form of the Type II TNF Receptor,”Virol. 204:343-356 (Oct. 1994).
Inui, S. et al., “Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40,”Eur. J. Immunol. 20:1747-1753 (1990).
Itoh, N. et al., “The Polypeptide Encoded by the cDNA for Human Cell Surface Antigen Fas Can Mediate Apoptosis,”Cell 66:233-243 (1991).
Johnson, D. et al., “Expression and Structure of the Human NGF Receptor,”Cell 47:545-554 (1986).
Kitson, J. et al. “A death-domain-comtaining receptor that mediates apoptosis,”Nature 384:372-375 (Nov. 1996).
Krammer, P.H. et al., “Regulation of apoptosis in the immune system,”Curr. Opin. Immunol. 6:279-289 (Apr. 1994).
Kwon, B.S. and S.M. Weissman, “cDNA sequences of two inducible T-cell genes,”Proc. Natl. Acad. Sci. USA 86:1963-1967 (1989).
Kwon, B.S. et al., “Genomic Organization and Chromosomal Localization of the T-Cell Antigen 4-1BB,”J. Immunol. 152:2256-2262 (Mar. 1994).
Lewis, M. et al., “Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific,”Proc. Natl. Acad. Sci. USA 88:2830-2834 (1991).
Loetscher, H. et al., “Molecular Cloning and Expression of the Human 55 kd Tumor Necrosis Factor Receptor,”Cell 61:351-359 (1990).
Mallett, S. et al., “Characterization of the MRC OX40 antigen of activated CD4 positive T Lymphocytes—a molecule related to nerve growth factor receptor,”EMBO J. 9(4):1063-1068 (1990).
Mallett, S. and A.N. Barclay, “A new superfamily of cell surface proteins related to the nerve growth factor receptor,”Immunol. Today 12(7):220-223 (1991).
Marsters, S. et al., “Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB,”Current Biology 6:1669-1676 (Dec. 1996).
Montgomery, R.I. et al., “A New Member of the TNG/NGF Receptor Family Can Mediate Herpes Simplex Virus 1 Entry Into Cells,”Eur. Cytokine Netw. 7(2):159, Abstract No. L7 (1996).
Muzio, M. et al., “FLICE, A Novel FADD-Homologous ICE/CED-3-like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex,”Cell 85:817-827 (Jun. 1996).
Nakagawa, T. et al., “Identification of an isoform with an extremely large Cys-rich region of PC6, a Kex2-like processing endoprotease,”FEBS Letter 327:165-171 (1993).
Nophar, Y. et al., “Soluble forms of tumor necrosis factor receptors (TNF-Rs). The

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Death domain containing receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Death domain containing receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Death domain containing receptors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3476159

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.